419 related articles for article (PubMed ID: 12536351)
21. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment.
Merli GJ
J Thromb Thrombolysis; 2004 Oct; 18(2):117-25. PubMed ID: 15789178
[TBL] [Abstract][Full Text] [Related]
22. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of deep venous thrombosis in medical patients].
Bergmann JF; Mahe I
Ann Med Interne (Paris); 2000 May; 151(3):207-14. PubMed ID: 10896973
[TBL] [Abstract][Full Text] [Related]
25. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
26. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
Daskalopoulos ME; Daskalopoulou SS; Liapis CD
Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis strategies for patients with acute venous thromboembolism.
Tapson VF
Am J Manag Care; 2001 Nov; 7(17 Suppl):S524-31; discussion S531-4. PubMed ID: 11732663
[TBL] [Abstract][Full Text] [Related]
28. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
Mismetti P; Laporte S; Darmon JY; Buchmüller A; Decousus H
Br J Surg; 2001 Jul; 88(7):913-30. PubMed ID: 11442521
[TBL] [Abstract][Full Text] [Related]
30. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials.
Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H
Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147
[TBL] [Abstract][Full Text] [Related]
31. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments.
Ellis MH; Elis A
Eur J Haematol; 2004 Aug; 73(2):104-8. PubMed ID: 15245509
[TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
Carroll DN; Hudson EB
Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
[TBL] [Abstract][Full Text] [Related]
34. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
[TBL] [Abstract][Full Text] [Related]
35. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
[TBL] [Abstract][Full Text] [Related]
36. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
38. Thromboprophylaxis in medical patients--why not for all?
Schulman S
Pathophysiol Haemost Thromb; 2006; 35(1-2):141-5. PubMed ID: 16855360
[TBL] [Abstract][Full Text] [Related]
39. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.
Spyropoulos AC
Chest; 2005 Aug; 128(2):958-69. PubMed ID: 16100192
[TBL] [Abstract][Full Text] [Related]
40. Discoveries in thrombosis care for medical patients.
Cohen AT
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():13-7. PubMed ID: 12232818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]